Omalizumab response in patients with chronic idiopathic urticaria: Insights from the XTEND-CIU study.
Casale TB, Win PH, Bernstein JA, Rosén K, Holden M, Iqbal A, Trzaskoma BL, Yang M, Antonova EN, Murphy T, Scarupa MD, Sofen H, Kaplan A.
Casale TB, et al. Among authors: murphy t.
J Am Acad Dermatol. 2018 Apr;78(4):793-795. doi: 10.1016/j.jaad.2017.10.010. Epub 2017 Oct 14.
J Am Acad Dermatol. 2018.
PMID: 29037993
Free article.
Clinical Trial.
No abstract available.